Collectively, these findings underscore the role of NOX2 in amplifying oxidative stress through ROS generation, suggesting that NOX2 could be a promising therapeutic target for treating pulmonary fibrosis, including silicosis [38,39]. This evidence concerns the gene CYBB and pulmonary fibrosis.